PGL 0.00% 44.5¢ prospa group limited.

In context, a disease incidence of 4.5 per 100,000 ain't too...

  1. 19 Posts.
    In context, a disease incidence of 4.5 per 100,000 ain't too bad.

    Chronic Myeloid Leukaemia (CML) has an incidence in the USA of approximately 2 per 100,000 (i.e. rarer than liver cancer).

    Gleevec (Novartis) is a blockbuster that generates most of its revenue from prescription to treat CML.

    Sales of Gleevec were US$2.5 BILLION in 2006.

    So there you go.....a disease with an indidence of 2 per 100,000 can generate the bulk of US$2.5 BILLION in annual sales...............

    Put that in ya PI-88 pipe and smoke it!

    Short sellers BEWARE!
 
watchlist Created with Sketch. Add PGL (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.